Loading…
Back To Schedule
Wednesday, September 27 • 12:00pm - 12:45pm
Strategize First-In-Human CAR-T and TCR-T Study Designs
Tweet Share
  •  Engineer T cells to provide the same discrimination between friend and foe as endogenous T cells 
  • Identify the indications most fitting for CARs and/or TCRs 
  • Mitigate the costs of genetically modifying T cells  
Moderators
avatar for Kimberly Ha

Kimberly Ha

Senior Director, Strategic Communications, FTI CONSULTING

Speakers
avatar for Vivien Chan

Vivien Chan

Vice President, Portfolio Management, EUREKA THERAPEUTICS
avatar for Dr. Laurence Cooper

Dr. Laurence Cooper

CEO, ZIOPHARM ONCOLOGY INC.
avatar for Manuel Litchman

Manuel Litchman

CEO, MUSTANG BIO

Wednesday September 27, 2017 12:00pm - 12:45pm EDT
Renaissance Boston Waterfront 606 Congress St, Boston, MA 02210
  Improving R&D Outcomes